10x Genomics, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
-58.57
Forward P/E Ratio
102.50
PEG Ratio
0.91
-74.47
Price-to-Sales (TTM)
4.14
3.29
6.24
Market Cap
2.64B
2.28B
Is it profitable?
Net Profit Margin (TTM)
-3.55%
Gross Profit Margin
70.39%
Diluted EPS (TTM)
-0.17
-2.98%
638.78M
Is it growing?
-2.60%
-2.61%
Is it risky?
2.05
10.00
5.90
81.39M
Who owns it?
113.83%
1.64%
18.82%
128.99M
115.09M
Does it pay?
0.00%
0.00%
--
--
How much cash?
539.85M
127.82M
124.55M
4.25
- Price
- 20.57
- Percent Change
- +0.07 (0.32%)
- Previous Close
- 20.50
- Open
- 20.64
- Low
- 20.27
- High
- 21.22
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$20.57
From 52W Low
+154.99%
From 52W High
-22.23%
Today
+0.32%
1Y Change
+116.70%
6M
$16.69
3M
$17.51
1M
$23.58
Today
$20.57
From 52W Low
+154.99%
From 52W High
-22.23%
Today
+0.32%
1Y Change
+116.70%
6M
$16.69
3M
$17.51
1M
$23.58
Today
$20.57
Above Average
within its 1-year price range
$20.57
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-12.8%
3M
+17.4%
6M
+23.2%
1Y
+116.7%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- 10x Genomics, Inc.
- Founded
- 2012
- CEO
- Serge Saxonov
- Employees
- 1,178
- Fiscal Year End
- Dec 31, 2025
- Address
6230 Stoneridge Mall Road
Pleasanton
California
94588
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.10xgenomics.com
Indicators
Operating Cash Flow
127.82M
Net Income
-22.66M
Warning Sign
-5.64
Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |
Indicators
Operating Cash Flow
127.82M
Net Income
-22.66M
Warning Sign
-5.64
Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-58.57
Forward P/E Ratio
102.50
PEG Ratio
0.91
-74.47
Price-to-Sales (TTM)
4.14
3.29
6.24
Market Cap
2.64B
2.28B
Is it profitable?
Net Profit Margin (TTM)
-3.55%
Gross Profit Margin
70.39%
Diluted EPS (TTM)
-0.17
-2.98%
638.78M
Is it growing?
-2.60%
-2.61%
Is it risky?
2.05
10.00
5.90
81.39M
Who owns it?
113.83%
1.64%
18.82%
128.99M
115.09M
Does it pay?
0.00%
0.00%
--
--
How much cash?
539.85M
127.82M
124.55M
4.25
- Price
- 20.57
- Percent Change
- +0.07 (0.32%)
- Previous Close
- 20.50
- Open
- 20.64
- Low
- 20.27
- High
- 21.22
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$20.57
From 52W Low
+154.99%
From 52W High
-22.23%
Today
+0.32%
1Y Change
+116.70%
6M
$16.69
3M
$17.51
1M
$23.58
Today
$20.57
From 52W Low
+154.99%
From 52W High
-22.23%
Today
+0.32%
1Y Change
+116.70%
6M
$16.69
3M
$17.51
1M
$23.58
Today
$20.57
Above Average
within its 1-year price range
$20.57
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-12.8%
3M
+17.4%
6M
+23.2%
1Y
+116.7%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- 10x Genomics, Inc.
- Founded
- 2012
- CEO
- Serge Saxonov
- Employees
- 1,178
- Fiscal Year End
- Dec 31, 2025
- Address
6230 Stoneridge Mall Road
Pleasanton
California
94588
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.10xgenomics.com
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |